Clinical Trials Browser

Completed × NIH × Leukemia-Lymphoma, Adult T-Cell × Clear all

NCT00924170 2023-11-14

Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia

Phase 1/2 Completed

18 enrolled 30 charts

LymphoidOther hematologic neoplasm

Leukemia, Leukemia-Lymphoma, Adult T-Cell

NCT02689453 2022-04-29

Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)

Phase 1 Completed

11 enrolled 16 charts

DermatologicLymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT00061048 2012-10-31

Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma

Phase 2 Completed

29 enrolled 11 charts

LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell

NCT00001941 2012-08-20

Anti-Tac for Treatment of Leukemia

Phase 1/2 Completed

34 enrolled 12 charts

LymphoidOther hematologic neoplasm

Diabetes Mellitus, Insulin-Dependent, 10, Leukemia, T-Cell, Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections